Zhai D, Godoi P, Sergienko E, Dahl R, Chan X, Brown B, Rascon J, Hurder A, Su Y, Chung TD, Jin C, Diaz P, Reed JC. "J Biomol Screen. 2011 Dec"
Overexpression with the anti-apoptotic Bcl-2 loved ones proteins occurs normally in human cancers. Bfl-1 is highly expressed in a few kinds of malignant cells, contributing considerably to tumor mobile survival and chemoresistance. Hence, it would be appealing to possess chemical antagonists of Bfl-1.
To this end, we devised a fluorescence polarization assay (FPA) applying Bfl-1 protein and fluorescein-conjugated Bid BH3 peptide, which was utilized for high-throughput screening of chemical library.
Approximately 66 000 compounds had been screened for your potential to inhibit BH3 peptide binding to Bfl-1, yielding 14 reproducible hits with ?Y50% displacement. Immediately after dose-response analysis and confirmation working with a secondary assay according to time-resolved fluorescence resonance power transfer (TR-FRET), two teams of Bfl-1-specific inhibitors were identified, which includes chloromaleimide and sulfonylpyrimidine sequence compounds.
Fluorescence Polarization Assay (FPA) generated for each from the 6 anti-apoptotic Bcl-2 proteins demonstrated selective binding of both classes of compounds to Bfl-1. Analogs in the sulfonylpyrimidine collection had been synthesized and in contrast with the original strike for Bfl-1 binding by each FPAs and TR-FRET assays.
The ensuing structure-activity relation analysis led for the chemical probe compound CID-2980973 (ML042). Collectively, these findings demonstrate the feasibility of utilizing the HTS assay for discovery of selective chemical inhibitors of Bfl-1.
2011年12月30日星期五
The monoamine oxidase A, a broad-spectrum inhibitor of fungal ABC and MFS transporter.
Holmes AR, Keniya MV, Ivnitski-Steele I, Monk BC, Lamping E, Sklar LA, Cannon RD. "Antimicrob Agents Chemother. 2011 Dec"
Resistance to the commonly employed azole antifungal fluconazole (FLC) can develop on account of over-expression of ATP-binding cassette (ABC) and major facilitator superfamily (MFS) plasma membrane transporters. An approach to conquering this resistance would be to identify inhibitors of those efflux pumps.
We have created a pump assay appropriate for high-throughput screening (HTS) that uses recombinant Saccharomyces cerevisiae strains hyper-expressing person transporters from the opportunistic fungal pathogen Candida albicans. The recombinant strains possess higher resistance to azoles and also other pump substrates as opposed to parental host strain.
A flow cytometry-based HTS, which measured elevated intracellular retention with the luminescent pump substrate rhodamine 6G (R6G) inside yeast cells, was utilized to screen the Prestwick Chemical Library (PCL) of 1200 marketed medication. 9 compounds were determined as hits as well as the monoamine-oxidase A inhibitor (MAOI) clorgyline was recognized being an inhibitor of two Do. albicans ABC efflux pumps, CaCdr1p and CaCdr2p.
Secondary in vitro assays confirmed inhibition of pump-mediated efflux by clorgyline. Clorgyline also reversed the FLC-resistance of S. cerevisiae strains expressing other person fungal ABC transporters (Candida glabrata Cdr1p or Candida krusei Abc1p) or the Do. albicans major facilitator superfamily (MFS) transporter Mdr1p. Recombinant strains had been also chemosensitized by clorgyline to other azoles (itraconazole and miconazole (MCZ)).
Importantly, clorgyline confirmed synergy with FLC towards FLC-resistant Do. albicans clinical isolates and also a Do. glabrata strain and inhibited R6G efflux from a FLC-resistant Do. albicans clinical isolate. Clorgyline is usually a novel broad-spectrum inhibitor of two courses of fungal efflux pumps that functions synergistically with azoles versus azole-resistant C. albicans and Do. glabrata strains.
Resistance to the commonly employed azole antifungal fluconazole (FLC) can develop on account of over-expression of ATP-binding cassette (ABC) and major facilitator superfamily (MFS) plasma membrane transporters. An approach to conquering this resistance would be to identify inhibitors of those efflux pumps.
We have created a pump assay appropriate for high-throughput screening (HTS) that uses recombinant Saccharomyces cerevisiae strains hyper-expressing person transporters from the opportunistic fungal pathogen Candida albicans. The recombinant strains possess higher resistance to azoles and also other pump substrates as opposed to parental host strain.
A flow cytometry-based HTS, which measured elevated intracellular retention with the luminescent pump substrate rhodamine 6G (R6G) inside yeast cells, was utilized to screen the Prestwick Chemical Library (PCL) of 1200 marketed medication. 9 compounds were determined as hits as well as the monoamine-oxidase A inhibitor (MAOI) clorgyline was recognized being an inhibitor of two Do. albicans ABC efflux pumps, CaCdr1p and CaCdr2p.
Secondary in vitro assays confirmed inhibition of pump-mediated efflux by clorgyline. Clorgyline also reversed the FLC-resistance of S. cerevisiae strains expressing other person fungal ABC transporters (Candida glabrata Cdr1p or Candida krusei Abc1p) or the Do. albicans major facilitator superfamily (MFS) transporter Mdr1p. Recombinant strains had been also chemosensitized by clorgyline to other azoles (itraconazole and miconazole (MCZ)).
Importantly, clorgyline confirmed synergy with FLC towards FLC-resistant Do. albicans clinical isolates and also a Do. glabrata strain and inhibited R6G efflux from a FLC-resistant Do. albicans clinical isolate. Clorgyline is usually a novel broad-spectrum inhibitor of two courses of fungal efflux pumps that functions synergistically with azoles versus azole-resistant C. albicans and Do. glabrata strains.
2011年12月21日星期三
Diversity Quantification of Chemical Libraries
Colliandre L, Le Guilloux V, Bourg S, Morin-Allory L. "J Chem Inf Model. 2011 Dec"
High Throughput Screening (HTS) can be a standard technique widely useful to find hit compounds within drug discovery projects. The high costs associated with such experiments have highlighted the necessity to carefully design screening libraries to avoid wasting resources. Molecular diversity is an established concept that's used to this end for many years.
A new approach to help quantify the molecular diversity of screening libraries is usually presented nowdays. The approach is dependent on the Delimited Reference Chemical Subspace (DRCS) strategy, a new method that can be used to delimit the densest subspace spanned by a reference library in a lower life expectancy 2D continuous space. An overall of twenty-two diversity indices have been implemented or adapted to the current methodology, which is used here to take out outliers and obtain another cell-based partition of that subspace.
The behavior these indices was assessed and compared in various extreme situations, and with respect to a set of theoretical rules that a diversity function should satisfy when libraries of different sizes have to be compared. Some gold standard indices are found inappropriate ordinary context, while none of the tested indices behave perfectly in all cases. Five DRCS-based indices accounting for different aspects of diversity were lastly selected, and a simple framework is proposed to use them effectively.
Current drug-discovery strategies are typically 'target-centric' and are based upon high-throughput screening of significant chemical libraries against nominated targets and a selection of lead compounds with optimized 'on-target' capacity and selectivity profiles.
However, high attrition of targeted agents in clinical development claim that combinations of targeted agents is going to be most effective in treating solid tumors in the event the biological networks that allow cancer cells to subvert monotherapies are identified and retargeted. Conventional drug-discovery and advancement strategies are suboptimal for any rational design and advancement of novel drug combinations.
In this article, we highlight several emerging technologies supporting some sort of less reductionist, more agile, drug-discovery and development approach for any rational design, validation, prioritization together with clinical development of innovative drug combinations.
High Throughput Screening (HTS) can be a standard technique widely useful to find hit compounds within drug discovery projects. The high costs associated with such experiments have highlighted the necessity to carefully design screening libraries to avoid wasting resources. Molecular diversity is an established concept that's used to this end for many years.
A new approach to help quantify the molecular diversity of screening libraries is usually presented nowdays. The approach is dependent on the Delimited Reference Chemical Subspace (DRCS) strategy, a new method that can be used to delimit the densest subspace spanned by a reference library in a lower life expectancy 2D continuous space. An overall of twenty-two diversity indices have been implemented or adapted to the current methodology, which is used here to take out outliers and obtain another cell-based partition of that subspace.
The behavior these indices was assessed and compared in various extreme situations, and with respect to a set of theoretical rules that a diversity function should satisfy when libraries of different sizes have to be compared. Some gold standard indices are found inappropriate ordinary context, while none of the tested indices behave perfectly in all cases. Five DRCS-based indices accounting for different aspects of diversity were lastly selected, and a simple framework is proposed to use them effectively.
Current drug-discovery strategies are typically 'target-centric' and are based upon high-throughput screening of significant chemical libraries against nominated targets and a selection of lead compounds with optimized 'on-target' capacity and selectivity profiles.
However, high attrition of targeted agents in clinical development claim that combinations of targeted agents is going to be most effective in treating solid tumors in the event the biological networks that allow cancer cells to subvert monotherapies are identified and retargeted. Conventional drug-discovery and advancement strategies are suboptimal for any rational design and advancement of novel drug combinations.
In this article, we highlight several emerging technologies supporting some sort of less reductionist, more agile, drug-discovery and development approach for any rational design, validation, prioritization together with clinical development of innovative drug combinations.
2011年12月20日星期二
Physical Metagenomic Libraries
Neufeld JD, Engel K, Cheng J, Moreno-Hagelsieb G, Rose DR, Charles TC. "Stand Genomic Sci. 2011 Nov"
Both sequence-based and activity-based exploitation of environmental DNA have supplied unprecedented accessibility for the genomic content of cultivated and uncultivated microorganisms. Despite the fact that scientists deposit microbial strains in tradition collections and DNA sequences in databases, activity-based metagenomic studies typically only publish sequences in the hits retrieved from specific screens.
Physical metagenomic libraries, conceptually similar to whole sequence datasets, are typically not straightforward to get by interested parties subsequent to publication.
In purchase to facilitate unrestricted distribution of metagenomic libraries, we suggest the adoption of open up source metagenomics, in line with the trend towards open up entry publishing, and related to culture- and mutant-strain collections that have been the backbone of classic microbiology and microbial genetics.
The concept of open up source metagenomics includes preparing of physical DNA libraries, ideally in adaptable vectors that facilitate screening inside a variety of host organisms, and pooling of clones so that simple aliquots that contains full libraries may be readily distributed upon ask for. Database deposition of related metadata and sequence data for each library gives scientists with info to choose essentially the most suitable libraries for further research projects.
As a beginning level, we have proven the Canadian MetaMicroBiome Library (CM(2)BL). The CM(two)BL can be a publicly accessible assortment of cosmid libraries containing environmental DNA from soils collected from across Canada, spanning several biomes. The screening libraries had been produced such which the cloned DNA might be simply transferred to Gateway compliant vectors, facilitating purposeful screening in virtually any surrogate microbial host for which you'll find accessible plasmid vectors.
The libraries, which we are placing within the manifeste domain, will be distributed upon ask for with no restriction to members of both the educational study community and market. This article invites the scientific community to adopt this philosophy of open up resource metagenomics to increase the utility of functional metagenomics beyond first publication, circumventing the will need to start from scratch with each new study venture.
Both sequence-based and activity-based exploitation of environmental DNA have supplied unprecedented accessibility for the genomic content of cultivated and uncultivated microorganisms. Despite the fact that scientists deposit microbial strains in tradition collections and DNA sequences in databases, activity-based metagenomic studies typically only publish sequences in the hits retrieved from specific screens.
Physical metagenomic libraries, conceptually similar to whole sequence datasets, are typically not straightforward to get by interested parties subsequent to publication.
In purchase to facilitate unrestricted distribution of metagenomic libraries, we suggest the adoption of open up source metagenomics, in line with the trend towards open up entry publishing, and related to culture- and mutant-strain collections that have been the backbone of classic microbiology and microbial genetics.
The concept of open up source metagenomics includes preparing of physical DNA libraries, ideally in adaptable vectors that facilitate screening inside a variety of host organisms, and pooling of clones so that simple aliquots that contains full libraries may be readily distributed upon ask for. Database deposition of related metadata and sequence data for each library gives scientists with info to choose essentially the most suitable libraries for further research projects.
As a beginning level, we have proven the Canadian MetaMicroBiome Library (CM(2)BL). The CM(two)BL can be a publicly accessible assortment of cosmid libraries containing environmental DNA from soils collected from across Canada, spanning several biomes. The screening libraries had been produced such which the cloned DNA might be simply transferred to Gateway compliant vectors, facilitating purposeful screening in virtually any surrogate microbial host for which you'll find accessible plasmid vectors.
The libraries, which we are placing within the manifeste domain, will be distributed upon ask for with no restriction to members of both the educational study community and market. This article invites the scientific community to adopt this philosophy of open up resource metagenomics to increase the utility of functional metagenomics beyond first publication, circumventing the will need to start from scratch with each new study venture.
2011年12月19日星期一
Discovery of Enoyl-Reductase (FabI) Inhibitors by Molecular Shape and Electrostatic Matching.
Hevener KE, Mehboob S, Su PC, Truong K, Boci T, Deng J, Ghassemi M, Cook JL, Johnson ME. "J Med Chem. 2011 Dec"
Enoyl-acyl carrier protein (ACP) reductase, FabI, is really a key enzyme in the bacterial fatty acid biosynthesis pathway (FAS II). FabI is definitely an NADH-dependent oxidoreductase that functions to cut down enoyl-ACP substrates inside a last stage of the pathway. The absence of this enzyme in humans tends to make it an attractive target for the development of new antibacterial agents.
FabI is known to be unresponsive to structure-based design efforts resulting from a high diploma of induced fit plus a cell versatile loop encompassing the energetic web page.
Here we discuss the improvement, validation, and careful app of a ligand-based virtual display used for your identification of novel inhibitors in the Francisella tularensis FabI focus on.
In this research, 4 known courses of FabI inhibitors had been utilised as templates for virtual screens that concerned molecular form and electrostatic matching. The plan ROCS was made use of to go looking a high throughput screening library for compounds that matched any with the four molecular form queries. Matching compounds were additional refined applying the system EON, which compares and scores compounds by matching electrostatic homes. Employing these approaches, fifty compounds had been chosen, ordered, and examined.
The examined compounds possessed novel chemical scaffolds when compared to the input question compounds. Numerous hits with low micromolar exercise were discovered and follow-up scaffold-based searches resulted within the identification of the lead sequence with submicromolar enzyme inhibition, high ligand efficiency, and also a novel scaffold.
Additionally, just about the most active compounds showed promising whole-cell antibacterial activity from various Gram-positive and Gram-negative species, such as the goal pathogen.
Enoyl-acyl carrier protein (ACP) reductase, FabI, is really a key enzyme in the bacterial fatty acid biosynthesis pathway (FAS II). FabI is definitely an NADH-dependent oxidoreductase that functions to cut down enoyl-ACP substrates inside a last stage of the pathway. The absence of this enzyme in humans tends to make it an attractive target for the development of new antibacterial agents.
FabI is known to be unresponsive to structure-based design efforts resulting from a high diploma of induced fit plus a cell versatile loop encompassing the energetic web page.
Here we discuss the improvement, validation, and careful app of a ligand-based virtual display used for your identification of novel inhibitors in the Francisella tularensis FabI focus on.
In this research, 4 known courses of FabI inhibitors had been utilised as templates for virtual screens that concerned molecular form and electrostatic matching. The plan ROCS was made use of to go looking a high throughput screening library for compounds that matched any with the four molecular form queries. Matching compounds were additional refined applying the system EON, which compares and scores compounds by matching electrostatic homes. Employing these approaches, fifty compounds had been chosen, ordered, and examined.
The examined compounds possessed novel chemical scaffolds when compared to the input question compounds. Numerous hits with low micromolar exercise were discovered and follow-up scaffold-based searches resulted within the identification of the lead sequence with submicromolar enzyme inhibition, high ligand efficiency, and also a novel scaffold.
Additionally, just about the most active compounds showed promising whole-cell antibacterial activity from various Gram-positive and Gram-negative species, such as the goal pathogen.
2011年12月18日星期日
the potential anticancer effects of fisetin on breast cancer cells.
Yang Pei-Ming, Tseng Ho-Hsing, Peng Chih-Wen, Chen Wen-Shu, Chiu Shu-Jun "International journal of oncology "
The final result of creating apoptotic defects in most cancers cells will be the primary obstacle that limits the therapeutic efficacy of anticancer agents, and hence the improvement of novel agents concentrating on novel non-canonical cell loss of life pathways has turn into an crucial mission for medical study. Fisetin (3,3,4,7-tetrahydroxyflavone) is actually a by natural means occurring flavonoid normally located in fruit and veggies.
In this research, we investigated the potential anticancer effects of fisetin on breast cancer cells. The outcome confirmed fisetin induced higher cytotoxicity in human breast most cancers MCF-7 than in MDA-MB-231 cells in any other case it didn't exert any detectable cytotoxicity in non-tumorigenic MCF-10A cells.
We located fisetin can bring about a novel type of atypical apoptosis in caspase-3-deficient MCF-7 cells, which was characterised by numerous apoptotic functions, including plasma membrane rupture, mitochondrial depolarization, activation of caspase-7, -8 and -9, and parp inhibitor, having said that, neither DNA fragmentation and phosphotidylserine (PS) externalization was noticed.
Although p53 was also activated by fisetin, the fisetin-induced apoptosis wasn't rescued from the p53 inhibitor pifithrin-alpha. In contrast, the fisetin-induced apoptosis inhibitors was abrogated by pan-caspase inhibitor z-VAD-fmk.
Furthermore, inhibition of autophagy by fisetin was revealed as additional path to prompt anticancer exercise in MCF-7 cells. These data let us to suggest that fisetin seems as a new possible anticancer agent which could be utilized to create a medical protocol of human breast cancers.
The final result of creating apoptotic defects in most cancers cells will be the primary obstacle that limits the therapeutic efficacy of anticancer agents, and hence the improvement of novel agents concentrating on novel non-canonical cell loss of life pathways has turn into an crucial mission for medical study. Fisetin (3,3,4,7-tetrahydroxyflavone) is actually a by natural means occurring flavonoid normally located in fruit and veggies.
In this research, we investigated the potential anticancer effects of fisetin on breast cancer cells. The outcome confirmed fisetin induced higher cytotoxicity in human breast most cancers MCF-7 than in MDA-MB-231 cells in any other case it didn't exert any detectable cytotoxicity in non-tumorigenic MCF-10A cells.
We located fisetin can bring about a novel type of atypical apoptosis in caspase-3-deficient MCF-7 cells, which was characterised by numerous apoptotic functions, including plasma membrane rupture, mitochondrial depolarization, activation of caspase-7, -8 and -9, and parp inhibitor, having said that, neither DNA fragmentation and phosphotidylserine (PS) externalization was noticed.
Although p53 was also activated by fisetin, the fisetin-induced apoptosis wasn't rescued from the p53 inhibitor pifithrin-alpha. In contrast, the fisetin-induced apoptosis inhibitors was abrogated by pan-caspase inhibitor z-VAD-fmk.
Furthermore, inhibition of autophagy by fisetin was revealed as additional path to prompt anticancer exercise in MCF-7 cells. These data let us to suggest that fisetin seems as a new possible anticancer agent which could be utilized to create a medical protocol of human breast cancers.
2011年12月15日星期四
The stereospecific compounds may be a novel technique for the treatment of non-small cell lung cancer (NSCLC).
Zhao Y, Turlington M, LaPar DJ, Jones DR, Harris DA, Kron IL, Pu L, Lau CL. "Ann Thorac Surg. 2011 Sep"
BACKGROUND,
With the exception of surgical treatment, the normal platinum-based chemotherapeutic agents are the favored remedy for non-small cell lung cancer (NSCLC), nevertheless little improvement (5-year survival) continues to be produced. Therefore it really is highly fascinating to create revolutionary therapeutic agents for NSCLC remedy.
METHODS,
Highly enantioselective artificial techniques had been developed as well as a broad Screening Library was proven. Cell toxicity, cell sensitivity, cell proliferation, cell invasion, and three-dimensional colony formation assays were utilized to evaluate the anticancer potential of these compounds in non-small-cell lung cancer (NSCLC) cell lines.
RESULTS,
We identified thepowerful anticancer exercise in 5 tested NSCLC cell lines. We additional synthesized a very pure R-form enantiomer of PL54 (PL54R) and its racemate (PL54Rac) and characterised their anticancer actions.
The results showed that PL54S is far more powerful than PL54R and PL54Rac towards the tested cell lines. Furthermore, much less mobile toxicity was observed in the regular human lung fibroblasts.
Similarly, PL54S shown greater anti-colony formation action in comparison with PL54R and PL54Rac. The mobile sensitivity assay exposed that PL54S and PL54Rac drastically suppressed cologenic formation comparedmight prove to become a novel method for your therapy of non-small-cell lung cancer (NSCLC).
BACKGROUND,
With the exception of surgical treatment, the normal platinum-based chemotherapeutic agents are the favored remedy for non-small cell lung cancer (NSCLC), nevertheless little improvement (5-year survival) continues to be produced. Therefore it really is highly fascinating to create revolutionary therapeutic agents for NSCLC remedy.
METHODS,
Highly enantioselective artificial techniques had been developed as well as a broad Screening Library was proven. Cell toxicity, cell sensitivity, cell proliferation, cell invasion, and three-dimensional colony formation assays were utilized to evaluate the anticancer potential of these compounds in non-small-cell lung cancer (NSCLC) cell lines.
RESULTS,
We identified thepowerful anticancer exercise in 5 tested NSCLC cell lines. We additional synthesized a very pure R-form enantiomer of PL54 (PL54R) and its racemate (PL54Rac) and characterised their anticancer actions.
The results showed that PL54S is far more powerful than PL54R and PL54Rac towards the tested cell lines. Furthermore, much less mobile toxicity was observed in the regular human lung fibroblasts.
Similarly, PL54S shown greater anti-colony formation action in comparison with PL54R and PL54Rac. The mobile sensitivity assay exposed that PL54S and PL54Rac drastically suppressed cologenic formation comparedmight prove to become a novel method for your therapy of non-small-cell lung cancer (NSCLC).
订阅：
博文 (Atom)